Formulation and biological activity of antineoplastic proteoglycans derived from Mycobacterium vaccae in chitosan nanoparticles

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 2, 1999, Pages 151-157

  Tian, Xin Xin ^a   Groves, Michael J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; CHITOSAN; DRUG VEHICLE; GELATIN; NANOPARTICLE; PROTEOGLYCAN; UREA;

ANALYZER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ARTIFICIAL MEMBRANE; CENTRIFUGE; CONTROLLED STUDY; CULTURE MEDIUM; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG ISOLATION; DRUG RELEASE; DRUG STRUCTURE; MOLECULAR WEIGHT; MOUSE; MYCOBACTERIUM VACCAE; NONHUMAN; SARCOMA; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032999930     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772268     Document Type: Article

References (27)

1. Akbuga, J., Bergisadi, N. (1996) 5-fluorouracil-loaded chitosan microspheres: preparation and release characteristics. J. Microencap. 13: 161-168
2. Aspden, T. J., Mason, J. D. T., Jones, N. S., Lowe, J., Skaugrud, Ø., Illum, L. (1997) Chitosan as a nasal delivery system: the effect of chitosan solutions on in-vitro and in-vivo mucociliary transport rates in human turbinates and volunteers. J. Pharm. Sci. 86: 509-513
3. Berthold, A., Cremer, K., Kreuter, J. (1996) Preparation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Contr. Rel. 39: 17-25
4. Calvo, P., Remuñan-López, C., Vila-Jato, J. L., Alonso, M. J. (1997) Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm. Res. 14: 1431-1436
5. Ciftci, K., Klegerman, M. E., Tian, X. X., Groves, M. J. (1996) In-vivo testing of coated hydroxypropylmethy-cellulose granules containing an antineoplastic glycan (PS4) using Caco-2 tumour cells. Pharm. Sci. 2: 357-360
6. Elcin, Y. M., Dixit, V., Gitnick, G. (1996) Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in-vitro and in-vivo studies. Art. Cell. Blood Subst. Immobil. Biotech. 24: 257-271
7. Friess, W., Zhou, W., Groves, M. J. (1996) In-vivo testing of collagen matrices containing PS1, an antineoplastic glycan against murine sarcoma cells. Pharm. Sci. 2: 121-124
8. Groves, M. J., Klegerman, M. E., Ciftci, K., Tian, X. X. (1995) Isolation, characterization and formulation of an antineoplastic glycan from cultures of Mycobacterium vaccae. J. Pharm. Pharmacol. 47: 1082
9. Hari, P. R., Chandy, T., Sharma, C. P. (1996) Chitosan/calcium alginate microcapsules for intestinal delivery of nitrofurantoin. J. Microencap. 13: 319-329
10. Hassan, E. E., Parish, R. C., Gallo, J. M. (1992) Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm. Res. 9: 390-397
11. Illum, L., Davis, S. S., Pawula, M., Fisher, A. N., Barrett, D. A., Farraj, N. F., Shaw, P. N. (1996) Nasal administration of morphine-6-glucuronide in sheep - a pharmacokinetics study. Biopharm. Drug Disp. 17: 717-724
12. Jameela, S. R., Jayakrishnan, A. (1995) Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vivo degradation of microspheres in rat muscle. Biomaterials 16: 769-775
13. Klegerman, M. E., Ujjainwala, L., Zeunert, P. (1991) High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine. Cancer Lett. 56: 137-145
14. Lehr, C. M., Bouwstra, J. A., Schacht, E. H., Juninger, H. E. (1992) In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78: 43-48
15. Liu, L.-S., Liu, S.-Q., Ng, S. Y., Froix, M., Ohno, T., Heller, J. (1997) Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J. Contr. Rel. 43: 65-74
16. Lou, Y. (1993) The isolation, properties and formulation of an antineoplastic agent derived from Bacillus Calmette-Guérine. Ph. D. thesis, University of Illinois at Chicago, Chicago, IL, pp 99-131
17. Luessen, H. L., de Leeuw, B. J., Langemeyer, M. W., de Boer, A. B., Verhoef, J. C., Junginger, H. E. (1996) Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in-vivo. Pharm. Res. 13: 1668-1672
18. Muzzarelli, R. A. (1997) Human enzymatic activities related to the therapeutic administration of chitin derivatives. Cell. Mol. Life Sci. 53: 131-140
19. Peluso, G., Patella, O., Rainier, M., Satin, M., Ambrosia, L., Celebre, D., Avalon, B., Balsam, G. (1994) Chitosan-mediated stimulation of macrophage function. Biomaterials 15: 1215-1220
20. Sawayanagi, Y., Nambu, N., Nagai, T. (1982) Use of chitosan for sustained-release preparations of water-soluble drugs. Chem. Pharm. Bull. 30: 4213-4215
21. Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., DeBoer, A. G., Vårum, K. M., Artursson, P. (1997) Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm. Res. 14: 923-929
22. Scrip (1997) Stanford Rook's TB therapy founders. No. 2273, p. 23
23. Scrip (1998) Stanford Rook/Onyvax sign cancer vaccine deal. No. 2321, p. 9
24. Shiraishi, S., Imai, T., Otagiri, M. (1993) Controlled release of indomethacin by chitosan-polyelectrolyte complex: optimization and in-vivo/in-vitro evaluation. J. Contr. Rel. 25: 217-225
25. Stanford, J. L., Stanford, C. A. (1994) Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659. Immunology 191: 555-563
26. Thanoo, B. C., Sunny, M. C., Jayakrishnan, A. (1992) Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals. J. Pharm. Pharmacol. 44: 283-286
27. Wang, R., Klegerman, M. E., Marsden, I., Sinnott, M., Groves, M. J. (1995) An antineoplastic glycan isolated from Mycobacterium bovis (BCG vaccine). Biochem. J. 311: 867-872